Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Emphysema on baseline lung cancer CT a sign of future mortality risk
“Lung cancer screening shouldn’t just be looking for nodules. That’s a small part of what we see on the CT scan.”
Exploring the link between left ventricular diastolic function and AFib
Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Health systems use AI to target patients who may have elevated Lp(a) levels
"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.
AHA expands efforts to spread the word about CKM syndrome
This is a rapidly growing area of interest in cardiology as research continues to find close links between heart disease and kidney disease.

Abbreviated MRI protocols present suitable alternatives for liver cancer screening

Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.

Routine abdominal CTs offer insight into cardiovascular risk

During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.

Screening efforts have helped avert millions of cancer-related deaths in recent decades

In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.

Example of the four types of breast tissue density. The density of fibroglandular tissue inside the breast impacts the ability to easily see cancers. Cancers are very easy to spot in fatty breasts, but are almost impossible to find in extremely dense breasts. These examples show craniocaudal mammogram findings characterized as almost entirely fatty (far left), scattered areas of fibroglandular density (second from left), heterogeneously dense (second from right), and extremely dense (far right). RSNA

What breast density status can tell us about cardiovascular risk

Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.

HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

Patients without PCPs struggle to access lung cancer screening, despite eligibility

It is estimated that up to one-third of the U.S. population does not have a primary care provider.

Breast cancer rates among women in their 30s are on the rise

Screening uptake for younger women has been steadily rising for years. Consequently, so have cancer rates among the population.

Radiologist Dana Ataya, MD, writes song to clear up confusion on breast cancer screening recs.

Singing radiologist pens song to clear up confusion about breast cancer screening recs

Dana Ataya, MD, is backed by Moffitt Cancer Center's band, The ReMissions.

Screening

Emphysema on baseline lung cancer CT a sign of future mortality risk

Exploring the link between left ventricular diastolic function and AFib

Late-stage prostate cancer diagnoses on the rise

Health systems use AI to target patients who may have elevated Lp(a) levels

AHA expands efforts to spread the word about CKM syndrome